Stephen Morse of the Law School and the Perelman School of Medicine comments on the hazards of misusing scientific terms in court that might have different meanings.
Perelman School of Medicine
NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine
After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.
Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.
Arthur Caplan of the Perelman School of Medicine discusses how Facebook can be compared to a will.
Kevin Volpp of the Perelman School of Medicine and the Wharton School says, “There’s not a lot of peer-reviewed evidence that achieves sustained improvements in health behavior and health outcomes.”
Arthur H. Rubenstein, Former Dean of Penn's Perelman School of Medicine, Receives Medal for Medical Service
PHILADELPHIA — Having a virtual copy of a patient’s blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased coronary artery and see if a drug like aspirin would be effective in reducing the size of such a clot.
Penn Study Confirms 2 Treatments for Age-related Macular Degeneration Provide Equal Vision Improvements
Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania.
Stephen Hahn of the Perelman School of Medicine, Ralph Muller of the Health System and Ezekiel Emanuel of the Perelman and the Wharton School comment on the increase of hospitals using proton therapy in cancer care.